Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience
Conclusions: In our population, there was no difference in terms of relapses occurrence, disability status, and the overall disease activity during a follow up of 24 months.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
More News: Brain | Copaxone | Disability | Gilenya | Italy Health | Multiple Sclerosis | Neurology | Pregnancy | Study | Tysabri | Women